Klinikum der Universitaet Muenchen AöR
Verified site
Munich, Germany
Rare diseases
Investigational molecules
Locations
A plain-language summary of the goals, design and what participants do
This clinical trial is focused on studying a type of cancer called colorectal cancer, specifically in patients who have a high risk of recurrence or have stage III disease. These patients have tumors that are either MSI-high (microsatellite instability-high) or MMR-deficient (mismatch repair-deficient), which are specific characteristics of the cancer cells. The study is for those who cannot receive or choose not to receive a common chemotherapy treatment known as oxaliplatin. The main goal of the study is to see if a medication called atezolizumab, also known by its code name RO5541267, can help improve the chances of staying cancer-free for three years after treatment.
The treatment being tested is atezolizumab, which is given as an infusion, meaning it is administered directly into the bloodstream through a vein. This study will also include a comparison with a placebo, which is a substance with no active medication, to see how effective atezolizumab is on its own. The study will last for up to 12 months, during which participants will receive the treatment and have regular check-ups to monitor their health and the status of their cancer.
Participants in the study will be closely monitored for any side effects or changes in their condition. The study aims to provide valuable information on whether atezolizumab can be a beneficial treatment option for patients with this specific type of colorectal cancer who are not suitable for standard chemotherapy. The results could potentially lead to new treatment options for these patients in the future.
The trial runs in 5 steps – from screening to follow-up. Each step says what happens and what the team monitors.
12 criteria
20 criteria
Tell us about your condition – we search every trial in Europe and connect you with the right site.
We usually reply within a few days
All sites with verified contact details – recruitment status may not be available; ask directly
Munich, Germany
Hamburg, Germany
Berlin, Germany
Where you can join this trial
Countries are shaded by recruitment status. Click a recruiting country to ask about joining there.
Not recruitingJoining a clinical trial can seem overwhelming. We guide you step by step, so you know exactly what to expect and how we support you through the process.
sourced from the EU Clinical Trials Register and site verification
Want to learn more about this trial or check if you can participate?
Tell us about your condition – we search every trial in Europe and connect you with the right site.